TAT-mediated peroxiredoxin 5 and 6 protein transduction protects against high-glucose-induced cytotoxicity in retinal pericytes

Life Sciences

Volumn 84, Issue 23-24, 2009, Pages 857-864

  Kubo, Eri ^a   Singh, Dhirendra P ^b   Fatma, Nigar ^b   Akagi, Yoshio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diabetes; Oxidative stress; Pericyte; Peroxiredoxin; Retinopathy

Indexed keywords

GLUCOSE; PEROXIREDOXIN; PEROXIREDOXIN 5; PEROXIREDOXIN 6; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERGLYCEMIA; NONHUMAN; PERICYTE; RAT; RETINA; SPRAGUE DAWLEY RAT; SWINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELLS, CULTURED; FEMALE; GLUCOSE; HIV-1; HUMANS; PERICYTES; PEROXIREDOXIN VI; PEROXIREDOXINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RETINA; SWINE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; RATTUS; SUIDAE;

EID: 67349227864     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.03.019     Document Type: Article

References (69)

1. Amano S., et al. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvascular Research 69 1-2 (2005) 45-55
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 4 (1991) 405-412
3. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48 1 (1999) 1-9
4. Becker-Hapak M., et al. TAT-mediated protein transduction into mammalian cells. Methods 24 3 (2001) 247-256
5. Chae H.Z., et al. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Research and Clinical Practice 45 2-3 (1999) 101-112
6. Chen J.W., et al. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Journal of Biological Chemistry 275 37 (2000) 28421-28427
7. Choi M.H., et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435 7040 (2005) 347-353
8. Chung S.S., et al. Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the American Society of Nephrology 14 8 Suppl 3 (2003) S233-S236
9. Chung Y.M., et al. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Research 21 2A (2001) 1129-1133
10. Dickinson J.L., et al. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. Journal of Biological Chemistry 270 46 (1995) 27894-27904
11. Du Y., et al. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radical Biology & Medicine 35 11 (2003) 1491-1499
12. Fatma N., et al. Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. Journal of Biological Chemistry 276 52 (2001) 48899-48907
13. -/-mice lens epithelial cells by reactive oxygen species: Increased expression and activation of TGFbeta. Cell Death and Differentiation 12 7 (2005) 734-750
14. 2+ homeostasis. Brain Research 1233 (2008) 63-78
15. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 6 (1988) 1189-1193
16. Gitlin J.D., and D'Amore P.A. Culture of retinal capillary cells using selective growth media. Microvascular Research 26 1 (1983) 74-80
17. Green M., and Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 6 (1988) 1179-1188
18. Haskins K., et al. Oxidative stress in type 1 diabetes. Annals of the New York Academy of Sciences 1005 (2003) 43-54
19. Inoguchi T., et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. Journal of the American Society of Nephrology 14 8 Suppl 3 (2003) S227-S232
20. Isermann K., et al. A peroxiredoxin specifically expressed in two types of pharyngeal neurons is required for normal growth and egg production in Caenorhabditis elegans. Journal of Molecular Biology 338 4 (2004) 745-755
21. Kanwar M., et al. Oxidative damage in the retinal mitochondria of diabetic mice: Possible protection by superoxide dismutase. Investigative Ophthalmology & Visual Science 48 8 (2007) 3805-3811
22. Karsan A., et al. Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. Journal of Biological Chemistry 271 44 (1996) 27201-27204
23. Kern T.S., et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Investigative Ophthalmology & Visual Science 41 12 (2000) 3972-3978
24. Kim H., et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. Journal of Biological Chemistry 275 24 (2000) 18266-18270
25. Kowluru R.A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52 3 (2003) 818-823
26. Kowluru R.A., and Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53 12 (2004) 3233-3238
27. Kowluru R.A., et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes 47 3 (1998) 464-469
28. Kowluru R.A., et al. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50 8 (2001) 1938-1942
29. Kubo E., et al. TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity. Am J Physiol Cell 294 3 (2008) C842-C855
30. Kubo E., et al. Cellular distribution of lens epithelium-derived growth factor (LEDGF) in the rat eye: Loss of LEDGF from nuclei of differentiating cells. Histochemistry and Cell Biology 119 4 (2003) 289-299
31. Kubo E., et al. Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: Role of AOP2. Biochemical and Biophysical Research Communications 314 4 (2004) 1050-1056
32. Kubo E., et al. Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis. Diabetologia 48 4 (2005) 790-798
33. Kubo E., et al. Development- and age-associated expression pattern of peroxiredoxin 6, and its regulation in murine ocular lens. Mechanism of Ageing and Development 127 3 (2006) 249-256
34. Kwong L.K., et al. Decreased mitochondrial hydrogen peroxide release in transgenic Drosophila melanogaster expressing intramitochondrial catalase. Archives of Biochemistry and Biophysics 383 2 (2000) 303-308
35. Li W., et al. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cellular and Molecular Biology (Noisy-le-grand) 45 1 (1999) 59-66
36. Lorenzi M., and Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44 7 (2001) 791-804
37. Lyu M.S., et al. Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences. Mammalian Genome 10 10 (1999) 1017-1019
38. Manea A., et al. Changes in oxidative balance in rat pericytes exposed to diabetic conditions. Journal of Cellular and Molecular Medicine 8 1 (2004) 117-126
39. Manevich Y., et al. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proceedings of the National Academy of Sciences of the United States of America 99 18 (2002) 11599-11604
40. Mann D.A., and Frankel A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO Journal 10 7 (1991) 1733-1739
41. Mizutani M., et al. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Journal of Clinical Investigation 97 12 (1996) 2883-2890
42. Morita T., et al. Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II. Current Neurovascular Research 2 2 (2005) 113-120
43. Nagahara H., et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Natural Medicines 4 12 (1998) 1449-1452
44. Neumann C.A., et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 6948 (2003) 561-565
45. Nishigori C., et al. Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cells. British Journal of Dermatology 153 Suppl 2 (2005) 52-56
46. Nishikawa T., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 6779 (2000) 787-790
47. Orhan H., et al. Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology 139 3 (1999) 219-232
48. Park S.H., et al. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clinical Cancer Research 6 12 (2000) 4915-4920
49. Peshenko I.V., and Shichi H. Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radical Biology & Medicine 31 3 (2001) 292-303
50. Peshenko I.V., et al. Bovine eye 1-Cys peroxiredoxin: Expression in E. coli and antioxidant properties. Journal of Ocular Pharmacology Ther 17 1 (2001) 93-99
51. Plaisant F., et al. Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radical Biology & Medicine 34 7 (2003) 862-872
52. Rakieten N., et al. Studies on the diabetogenic action of streptozoticin. Cancer Chemotherapy Reports 29 (1963) 91-98
53. Ribeiro M.M., et al. Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochemical and Biophysical Research Communications 305 4 (2003) 876-881
54. Rosen P., et al. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metabolism Research and Reviews 17 3 (2001) 189-212
55. Rusnati M., et al. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. Journal of Biological Chemistry 272 17 (1997) 11313-11320
56. Sakurai T., and Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Letters 236 2 (1988) 406-410
57. Sato S., et al. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 64 6 (2005) 1081-1083
58. Schwarze S.R., and Dowdy S.F. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA. Trends in Pharmacological Sciences 21 2 (2000) 45-48
59. Setter S.M., et al. Biochemical pathways for microvascular complications of diabetes mellitus. Annals of Pharmacotherapy 37 12 (2003) 1858-1866
60. Sharpe P.C., et al. Glucose-induced oxidative stress in vascular contractile cells: Comparison of aortic smooth muscle cells and retinal pericytes. Diabetes 47 5 (1998) 801-809
61. Sherman D.R., et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272 5268 (1996) 1641-1643
62. Shokolenko I.N., et al. TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells. DNA Repair (Amst) 4 4 (2005) 511-518
63. Tarng D.C., et al. 8-hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. American Journal of Kidney Diseases 36 5 (2000) 934-944
64. Verdoucq L., et al. In vivo characterization of a thioredoxin h target protein defines a new peroxiredoxin family. Journal of Biological Chemistry 274 28 (1999) 19714-19722
65. 2-sensing by the antioxidant Pap1 pathway. Proceedings of the National Academy of Sciences of the United States of America 102 25 (2005) 8875-8880
66. Vocero-Akbani A., et al. Transduction of full-length Tat fusion proteins directly into mammalian cells: Analysis of T cell receptor activation-induced cell death. Methods in Enzymology 322 (2000) 508-521
67. Wood Z.A., et al. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 5619 (2003) 650-653
68. Wood Z.A., et al. Structure, mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences 28 1 (2003) 32-40
69. Zhou Y., et al. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochemical and Biophysical Research Communications 268 3 (2000) 921-927